What is the recommended thromboprophylaxis for a postpartum woman, with a body weight of 128kg, after a cesarean delivery for twins?

Thromboprophylaxis After Cesarean Delivery for Twins in a 128kg Woman

This patient requires both mechanical and pharmacologic thromboprophylaxis with intermediate-dose enoxaparin 40mg subcutaneously every 12 hours plus sequential compression devices, given her Class III obesity (128kg) and multiple pregnancy. 1, 2

Risk Stratification

This patient has multiple VTE risk factors that mandate combined prophylaxis:

• Cesarean delivery - inherently increases VTE risk 4-fold compared to vaginal delivery 3
• Class III obesity (BMI ≥40 at 128kg) - classified as a major risk factor 1, 2
• Multiple pregnancy (twins) - classified as a minor risk factor 1

The combination of cesarean delivery plus Class III obesity plus twin gestation places this patient in the high-risk category requiring both mechanical and pharmacologic prophylaxis. 1, 2

Recommended Prophylaxis Regimen

Mechanical Prophylaxis

• Apply sequential compression devices before surgery and continue until the patient is fully ambulatory (GRADE 1C) 1, 2
• This is mandatory for all women undergoing cesarean delivery regardless of other risk factors 1

Pharmacologic Prophylaxis

For Class III obesity, standard prophylactic dosing is inadequate. 2

• Enoxaparin 40mg subcutaneously every 12 hours (intermediate dosing) rather than the standard 40mg once daily 2
• This intermediate dosing is specifically recommended because standard-dose enoxaparin (40mg once daily) results in subtherapeutic anti-Xa levels in the majority of patients with BMI ≥40 2
• Low-molecular-weight heparin is the preferred thromboprophylactic agent in the postpartum period (GRADE 1C) 1, 2

Timing of Initiation

• Initiate intermediate-dose enoxaparin as early as 4 hours after epidural catheter removal, but not earlier than 24 hours after neuraxial block was performed 2

Duration of Prophylaxis

• Continue mechanical prophylaxis until fully ambulatory 1, 2
• Continue pharmacologic prophylaxis for at least 10 days postpartum, with consideration for extension up to 6 weeks if additional risk factors persist 1, 2
• Given this patient's multiple persistent risk factors (obesity, twin pregnancy), extended prophylaxis for 6 weeks should be strongly considered 1, 2

Special Considerations

Renal Function Assessment

• Verify creatinine clearance before initiating enoxaparin 2
• If creatinine clearance <30 mL/min, use unfractionated heparin (5,000-10,000 units subcutaneously every 8-12 hours) instead of enoxaparin 2

Alternative Agents to Avoid

• Do not use direct oral anticoagulants (DOACs) such as apixaban, rivaroxaban, or dabigatran in the postpartum period—insufficient safety data exists 2
• Warfarin is not appropriate for immediate postpartum prophylaxis; LMWH is the agent of choice 2

Common Pitfalls to Avoid

1. Do not use standard-dose enoxaparin (40mg once daily) in Class III obesity—this dosing is inadequate and results in subtherapeutic levels 2

2. Do not rely on mechanical prophylaxis alone—pharmacologic prophylaxis is necessary given the high-risk profile 1, 2

3. Do not stop prophylaxis at hospital discharge—extend for the full recommended duration based on persistent risk factors 1, 2

4. Do not continue LMWH up to delivery time if neuraxial anesthesia was used—ensure appropriate timing after epidural removal 2

Institutional Protocol Recommendation

Each institution should develop a standardized patient safety bundle with a protocol for VTE prophylaxis among women undergoing cesarean delivery (Best Practice recommendation). 1, 2